# Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

> **NCT00510952** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 471 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Lispro Protamine Suspension
- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT00510952
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 471 (ACTUAL)
- **Last updated:** 2010-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510952, "Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00510952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*